Skip to main content

Advertisement

SpringerLink
Log in

Transiliac bone biopsy in osteoporosis: frequency, indications, consequences and complications. An evaluation of 99 consecutive cases over a period of 14 years

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Bone biopsy is a diagnostic procedure restricted to untypical, unclear and complicated cases in evidence-based guidelines on diagnosis and treatment of osteoporosis. Its relevance has been a topic of recent controversial discussion. This study was performed to evaluate its role and relevance in routine use. A total of 99 horizontal transiliac bone biopsies performed over a time period of 14 years because of an osteological indication in one single centre were analysed, which reflects that bone biopsy followed about 0.003% of patients’ consultations. Bone biopsies were indicated for osteoporotic males (n=63) and premenopausal osteoporotic females (n=18) without endocrine abnormality and normal immunofixation (serum and urine), suspected systemic/malignant disease such as mastocytosis, osteogenesis imperfecta, non-secreting plasmocytoma, metastatic infiltration (n=16) and decreasing bone mineral density under anti-osteoporotic treatment (n=2). The most frequent diagnoses besides osteoporosis were normal histology, borderline finding towards mild osteoporosis, and osteoporomalacia with relevant osteoidosis. In some cases, pathological findings in bone marrow were detected. In most cases (82/99), bone biopsy led to consequences in medical treatment. Following histopathological diagnosis, 16 patients did not receive any anti-osteoporotic treatment. In six patients, further diagnostic procedures were initiated because of bone histology. Bone biopsy was well tolerated and complications were rare and mild. In conclusion, despite all progress in non-invasive diagnostic procedures for metabolic bone diseases such as osteoporosis, there remains a small but significant subset of patients who may benefit from inclusion of bone biopsy into the diagnostic procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kruse H-P, Kuhlencordt F (1984) Grundzüge der Osteologie. Springer-Verlag, Berlin Heidelberg New York Tokyo

    Google Scholar 

  2. Malluche HH, Faugere M-C (1990) Bone biopsies: histology and histomorphometry of bone. In: Avioli LV, Krane SM (eds) Metabolic bone disease and clinically related disorders. WB Saunders Company, Philadelphia, pp 283–328

    Google Scholar 

  3. Meunier PJ (1988) Assessment of bone turnover by histomorphometry in osteoporosis. In: Riggs BL, Melton LJ (eds) Osteoporosis—etiology, diagnosis and management. Raven Press, New York, pp 317–332

    Google Scholar 

  4. Kann PH (2001) Bone densitometry and ultrasound studies of the bone: methods, indications and efficacy. Orthopäde 30:437–443

    Article  CAS  PubMed  Google Scholar 

  5. Pfeilschifter J, Kann PH (2002) Evaluation of osteoporosis. Z Gastroenterol 40 [Suppl 1]:S46–S56

    Article  PubMed  Google Scholar 

  6. Ettinger MP (2003) Aging bone and osteoporosis: strategies for preventing fractures in the elderly. Arch Intern Med 163:2237–2246

    PubMed  Google Scholar 

  7. Kenny AM, Joseph C, Taxel P, Prestwood KM (2003) Osteoporosis in older men and women. Conn Med 67:481–486

    PubMed  Google Scholar 

  8. Scheidt-Nave C, Baum E, Dören M, Hadji P, Keck E, Minne E, Seibel M (2003) DVO-Leitlinie Osteoporose bei postmenopausalen Frauen. Osteologie 12:13–41

    Google Scholar 

  9. Fassbender WJ, Scheidt-Nave Ch, Pfeilschifter J, Dachverband der Deutschsprachigen Osteologischen Fachgesellschaften (2003) Evidence-based clinical practice guidelines for diagnosis and treatment of osteoporosis. Dtsch Med Wochenschr 128:1615–1616

    Article  CAS  PubMed  Google Scholar 

  10. Hauge E, Mosekilde LE, Melsen F (1999) Missing observations in bone histomorphometry on osteoporosis: implications and suggestions for an approach. Bone 25:389–395

    Article  CAS  PubMed  Google Scholar 

  11. Ziegler R (2002) Osteoporose: aktuelle Diagnostik und Therapie. Orthopädische Praxis 38:570–577

    Google Scholar 

  12. Mehl B, Delling G, Schlindwein I, Heilmann P, Voia C, Ziegler R, Nawroth P, Kasperk C (2002) Do markers of bone metabolism reflect the presence of a high- or low-turnover state of bone metabolism? Med Klin 97:588–594

    Article  CAS  PubMed  Google Scholar 

  13. Allolio B (2003) Role of bone histology in the determination of bone metabolism. Med Klin 98:110

    CAS  PubMed  Google Scholar 

  14. Barthel HR, Seibel MJ (2003) Role of bone histology in the determination of bone metabolism. Med Klin 98:111–112

    Article  PubMed  Google Scholar 

  15. Bordier P, Matrajt H, Miravet L, Hioco D (1964) Mesure histologique de la masse et de la résorption des travées osseuses. Pathol Biol 12:1238–1243

    CAS  PubMed  Google Scholar 

  16. Hahn M, Vogel M, Delling G (1991) Undecalcified preparation of bone tissue: report of technical experience and development of new methods. Virchows Arch A Pathol Anat 418:1–7

    Article  CAS  Google Scholar 

  17. Delling G, Werner M (2001) Ist die histologische Untersuchung des Knochengewebes noch zeitgemäß? Osteologie 10:3–14

    Google Scholar 

  18. Lücking Th, Delling G (1973) Schwere rachitische Osteopathie bei antiepileptischer Langzeitbehandlung. Dtsch Med Wochenschr 98:1036–1040

    PubMed  Google Scholar 

  19. The Writing Group for the ISCD Position Development Conference (2004) Technical standardization for dual-energy X-ray absorptiometry. J Clin Densitom 7:27–36

    Google Scholar 

  20. Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papaioannou A, Robinson V, Shea B, Wells G, Guyatt G, Osteoporosis Methodology Group and the Osteoporosis Research Advisory Group (2002) Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocrinol Rev 23:517–523

    Article  CAS  Google Scholar 

  21. Cranney A, Tugwell P, Zytaruk N, Robinson V, Weaver B, Adachi J, Wells G, Shea B, Guyatt G, Osteoporosis Methodology Group and the Osteoporosis Research Advisory Group (2002) Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocrinol Rev 23:524–528

    Article  CAS  Google Scholar 

  22. Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, Black D, Adachi J, Shea B, Tugwell P, Guyatt G, Osteoporosis Methodology Group and the Osteoporosis Research Advisory Group (2002) Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocrinol Rev 23:508–516

    Article  CAS  Google Scholar 

  23. Thomson JS, Ebbesen EN, Mosekilde LE (2002) Predicting human vertebral bone strength by vertebral static histomorphometry. Bone 30:502–508

    Article  PubMed  Google Scholar 

  24. Hodgson SF, Johnson KA, Muhs JM, Lufkin EG, McCarthy JT (1986) Outpatient percutaneous biopsy of the iliac crest: methods, morbidity, and patient acceptance. Mayo Clin Proc 61:28–33

    CAS  PubMed  Google Scholar 

  25. Legrand E, Chappard D, Pascaretti C, Duquenne M, Krebs S, Rohmer V, Basle MF, Audran M (2000) Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis. J Bone Miner Res 15:13–19

    CAS  PubMed  Google Scholar 

  26. Oleksik A, Ott SM, Vedi S, Bravenboer N, Compston J, Lips P (2000) Bone structure in patients with low bone mineral density with or without vertebral fractures. J Bone Miner Res 15:1368–1375

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was conducted at the Departments of Endocrinology and Metabolic Diseases, Johannes Gutenberg University Hospital, Mainz and Osteopathology, Eppendorf University Hospital, Hamburg, Germany.

Author information

Authors and Affiliations

  1. Division of Endocrinology and Diabetology, Philipp’s University Hospital, 35033, Marburg, Germany

    P.H. Kann & S. Meyer

  2. Department of Endocrinology and Metabolic Diseases, Johannes Gutenberg University Hospital, Mainz, Germany

    P.H. Kann, A. Pfützner, G. Schulz & S. Meyer

  3. Department of Osteopathology, Eppendorf University Hospital, Hamburg, Germany

    G. Delling

  4. Institute for Clinical Research and Development, Mainz, Germany

    P.H. Kann & A. Pfützner

Authors
  1. P.H. Kann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Pfützner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Delling
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Schulz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P.H. Kann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kann, P., Pfützner, A., Delling, G. et al. Transiliac bone biopsy in osteoporosis: frequency, indications, consequences and complications. An evaluation of 99 consecutive cases over a period of 14 years. Clin Rheumatol 25, 30–34 (2006). https://doi.org/10.1007/s10067-005-1132-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-005-1132-7

Keywords

Search

Navigation